Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Xalkori
(crizotinib)Orphan drugstandardPfizer, Inc.
Kinase Inhibitor [EPC]
12.1 Mechanism of Action Crizotinib is an inhibitor of receptor tyrosine kinases including ALK, Hepatocyte Growth Factor Receptor (HGFR, c-Met), ROS1 ...
Jessica Gartrell, MD, MD
St. Jude Children's Research Hospital
📍 MEMPHIS, TN
Aaron R Weiss
Children's Oncology Group
Michel Zwaan, Prof
Princess Maxima Center for Pediatric Oncology in The Netherlands
Zi-Qi Tao, MD
Science and Education Division of Xuzhou Central Hospital
Xuan Wang
Peking Union Medical College Hospital
Brendan C Dickson
University of Toronto
📍 HURRICANE, WV